INS and diabetes mellitus: A multiple linear regression was calculated to predict glycemic outcomes (HbA1c, 90-day mean glucose, and 90-day time >250 mg/dL (>13.9 mmol/L)) based on current age, duration of diabetes, race, insurance status, and insulin administration type (reference values = privately insured, NHW, pump use, male).